Evaluation of cataract surgery and lens implantation in diabetics

Comparison of glistenings in two hydrophobic acrylic intraocular lenses after cataract surgery in diabetics: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN93583656

Enrollment

Registered

2009-12-15

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Eye Diseases Other cataract

Interventions

AVS hydrophobic intraocular lens versus AcrySof® intraocular lens. Patients will be randomised to have routine cataract surgery to one eye with implantation of either the Santen or the AcrySof® lens.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Bilateral cataracts requiring surgery 2. Diabetic 3. Aged 18 years or over, either sex

Exclusion criteria

Exclusion criteria: Diabetic maculopathy

Design outcomes

Primary

Measure	Time frame
1. Glistenings 2. Vision Taken at 1, 3, 6, 12, 24 and 36 months.	—

Secondary

Measure	Time frame
1. Post-operative inflammation after cataract surgery and cellular deposition on the IOL surface 2. Objective optical quality and wave-front aberration 3. Contrast sensitivity 4. Diabetic retinopathy after cataract surgery Taken at 1, 3, 6, 12, 24 and 36 months.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026